vs
Side-by-side financial comparison of Origin Bancorp, Inc. (OBK) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $104.0M, roughly 1.6× Origin Bancorp, Inc.). Origin Bancorp, Inc. runs the higher net margin — 26.6% vs -82.0%, a 108.6% gap on every dollar of revenue. Over the past eight quarters, Origin Bancorp, Inc.'s revenue compounded faster (3.9% CAGR vs -11.5%).
Southern Bancorp is a community development financial institution headquartered in Arkadelphia, Arkansas. It was founded in 1986 as Southern Development Bancorporation, and is often referred to simply as "Southern".
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
OBK vs PTCT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $104.0M | $164.7M |
| Net Profit | $27.7M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | — | -43.3% |
| Net Margin | 26.6% | -82.0% |
| Revenue YoY | — | -22.7% |
| Net Profit YoY | — | -104.8% |
| EPS (diluted) | $0.89 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $104.0M | — | ||
| Q4 25 | $103.4M | $164.7M | ||
| Q3 25 | $109.8M | $211.0M | ||
| Q2 25 | $83.5M | $178.9M | ||
| Q1 25 | $94.1M | $1.2B | ||
| Q4 24 | $78.3M | $213.2M | ||
| Q3 24 | $90.8M | $196.8M | ||
| Q2 24 | $96.4M | $186.7M |
| Q1 26 | $27.7M | — | ||
| Q4 25 | $29.5M | $-135.0M | ||
| Q3 25 | $8.6M | $15.9M | ||
| Q2 25 | $14.6M | $-64.8M | ||
| Q1 25 | $22.4M | $866.6M | ||
| Q4 24 | $14.3M | $-65.9M | ||
| Q3 24 | $18.6M | $-106.7M | ||
| Q2 24 | $21.0M | $-99.2M |
| Q1 26 | — | — | ||
| Q4 25 | 36.2% | -43.3% | ||
| Q3 25 | 10.0% | 1.4% | ||
| Q2 25 | 22.3% | -19.5% | ||
| Q1 25 | 30.4% | 82.5% | ||
| Q4 24 | 23.0% | -76.2% | ||
| Q3 24 | 26.1% | -27.7% | ||
| Q2 24 | 27.7% | -21.5% |
| Q1 26 | 26.6% | — | ||
| Q4 25 | 28.5% | -82.0% | ||
| Q3 25 | 7.9% | 7.5% | ||
| Q2 25 | 17.5% | -36.3% | ||
| Q1 25 | 23.8% | 73.7% | ||
| Q4 24 | 18.2% | -30.9% | ||
| Q3 24 | 20.5% | -54.2% | ||
| Q2 24 | 21.8% | -53.1% |
| Q1 26 | $0.89 | — | ||
| Q4 25 | $0.95 | $-1.63 | ||
| Q3 25 | $0.27 | $0.20 | ||
| Q2 25 | $0.47 | $-0.83 | ||
| Q1 25 | $0.71 | $10.04 | ||
| Q4 24 | $0.45 | $-0.85 | ||
| Q3 24 | $0.60 | $-1.39 | ||
| Q2 24 | $0.67 | $-1.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $-205.3M |
| Total Assets | $10.2B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $424.2M | $1.9B | ||
| Q3 25 | $626.9M | $1.7B | ||
| Q2 25 | $334.1M | $2.0B | ||
| Q1 25 | $486.2M | $2.0B | ||
| Q4 24 | $470.2M | $1.1B | ||
| Q3 24 | $321.2M | $1.0B | ||
| Q2 24 | $288.1M | $1.1B |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.2B | $-205.3M | ||
| Q3 25 | $1.2B | $-155.8M | ||
| Q2 25 | $1.2B | $-206.5M | ||
| Q1 25 | $1.2B | $-185.8M | ||
| Q4 24 | $1.1B | $-1.1B | ||
| Q3 24 | $1.1B | $-1.1B | ||
| Q2 24 | $1.1B | $-980.2M |
| Q1 26 | $10.2B | — | ||
| Q4 25 | $9.7B | $2.9B | ||
| Q3 25 | $9.8B | $2.6B | ||
| Q2 25 | $9.7B | $2.6B | ||
| Q1 25 | $9.8B | $2.7B | ||
| Q4 24 | $9.7B | $1.7B | ||
| Q3 24 | $10.0B | $1.8B | ||
| Q2 24 | $9.9B | $1.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-34.3M |
| Free Cash FlowOCF − Capex | — | $-36.6M |
| FCF MarginFCF / Revenue | — | -22.3% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $158.9M | $-34.3M | ||
| Q3 25 | $59.3M | $-66.3M | ||
| Q2 25 | $20.6M | $-58.3M | ||
| Q1 25 | $35.6M | $870.1M | ||
| Q4 24 | $108.5M | $-30.0M | ||
| Q3 24 | $39.6M | $-77.0M | ||
| Q2 24 | $11.9M | $-71.5M |
| Q1 26 | — | — | ||
| Q4 25 | $151.1M | $-36.6M | ||
| Q3 25 | $56.8M | $-69.7M | ||
| Q2 25 | $19.6M | $-59.6M | ||
| Q1 25 | $34.8M | $868.4M | ||
| Q4 24 | $86.4M | $-33.8M | ||
| Q3 24 | $32.2M | $-77.5M | ||
| Q2 24 | $6.5M | $-78.8M |
| Q1 26 | — | — | ||
| Q4 25 | 146.0% | -22.3% | ||
| Q3 25 | 51.7% | -33.1% | ||
| Q2 25 | 23.5% | -33.3% | ||
| Q1 25 | 37.0% | 73.8% | ||
| Q4 24 | 110.3% | -15.8% | ||
| Q3 24 | 35.5% | -39.4% | ||
| Q2 24 | 6.8% | -42.2% |
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | 1.4% | ||
| Q3 25 | 2.3% | 1.6% | ||
| Q2 25 | 1.2% | 0.7% | ||
| Q1 25 | 0.8% | 0.1% | ||
| Q4 24 | 28.1% | 1.8% | ||
| Q3 24 | 8.1% | 0.3% | ||
| Q2 24 | 5.6% | 4.0% |
| Q1 26 | — | — | ||
| Q4 25 | 5.38× | — | ||
| Q3 25 | 6.88× | -4.17× | ||
| Q2 25 | 1.41× | — | ||
| Q1 25 | 1.59× | 1.00× | ||
| Q4 24 | 7.60× | — | ||
| Q3 24 | 2.13× | — | ||
| Q2 24 | 0.57× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OBK
| Net Interest Income | $87.2M | 84% |
| Noninterest Income | $16.8M | 16% |
PTCT
Segment breakdown not available.
